Look for:

Products

ELEVANCE HEALTH INC.


ISIN:
US0367521038
WKN:
036752103

2024/04/18 22:00:01
Price
525.19 USD
Difference 3.19% (16.22)

General attributes

ISINUS0367521038
SymbolELV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)114,541 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)515.00 USD (200)
Ask (Ask size)529.25 USD (200)
Open520.58 USD
High539.11 USD
Low520.58 USD
Close (prev. day)508.97 USD
VWAP528.927812 USD
Volume (pcs)2,595,028
Trading volume1,373,847,960.18
Number of trades57,832
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ELEVANCE HEALTH INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/18 22:00:01
Price
525.19 USD
Difference 3.19% (16.22)

General attributes

ISINUS0367521038
SymbolELV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)114,541 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)515.00 USD (200)
Ask (Ask size)529.25 USD (200)
Open520.58 USD
High539.11 USD
Low520.58 USD
Close (prev. day)508.97 USD
VWAP528.927812 USD
Volume (pcs)2,595,028
Trading volume1,373,847,960.18
Number of trades57,832
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+11.91%+8.72%+39.82%
Perf (abs.)+55.88+42.11+149.57
Beta0.340.450.56
Volatility16.3121.5724.59
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)507.74 USD (1,466,812)
Ø price 30 days | Ø volume 30 days (pcs.)509.54 USD (1,005,250)
Ø price 100 days | Ø volume 100 days (pcs.)492.89 USD (1,066,866)
Ø price 250 days | Ø volume 250 days (pcs.)469.99 USD (1,129,859)
YTD High | date539.11 USD (2024/04/18)
YTD Low | date449.02 USD (2024/01/18)
52 Weeks High | date539.11 USD (2024/04/18)
52 Weeks Low | date412.00 USD (2023/07/12)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/10/2517:35430.00 EUR0.002
Vienna Stock Exchange2024/04/1817:32496.20 EUR0.002
Tradegate2024/04/1822:26493.60 EUR0.0412
Stuttgart2024/04/1821:57492.50 EUR0.007
NYSE2024/04/1822:00525.19 USD1,373.8557,832
Munich2024/04/1818:35497.60 EUR0.002
London Stock Exchange2024/04/1815:46529.35 USD0.012
Frankfurt2024/04/1808:24476.10 EUR0.002
Euronext Milan MTF Trading After Hours---0.00-
Euronext Milan MTF Global Equity Market2024/04/1817:44476.80 EUR0.001
Duesseldorf2024/04/1819:31495.90 EUR0.007
Berlin2024/04/1808:08476.50 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2314&ID_TYPE_IMAGE_LOGO=2

Contact Details

ELEVANCE HEALTH INC.
- -
220 Virginia Avenue - 46204 Indianapolis
Telefon: +1-800-331-1476
Fax: +
E-mail: -

PDF Downloads

Company report: ELEVANCE HEALTH INC.PDF Download

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Members of Management Board

Elizabeth TallettChairman of Board of Directors
Bahija JallalMember of Board of Directors
Ryan SchneiderMember of Board of Directors
Antonio NeriMember of Board of Directors
Deanna Strable-SoethoutMember of Board of Directors
Lewis HayMember of Board of Directors
R. ClarkMember of Board of Directors
Ramiro PeruMember of Board of Directors
Robert DixonMember of Board of Directors
Susan DeVoreMember of Board of Directors
Gail K. BoudreauxChairman of Managing Board
Shantanu AgrawalMember of Executive Committee
Bill BeckMember of Executive Committee
Blair TodtMember of Executive Committee
Bryony WinnMember of Executive Committee
Felicia F. NorwoodMember of Executive Committee
Gloria McCarthyMember of Executive Committee
Hakon MattsonMember of Executive Committee
John E. GallinaMember of Executive Committee
Kyle WeberMember of Executive Committee
Mark KayeMember of Executive Committee
Morgan KendrickMember of Executive Committee
Peter D. HaytaianMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.